Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?

By Casper Robert F.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1144-1146

Oxford University Press

Access to resources Recommend Favorite

Case report. High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization

By de Jong D  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 573-575

Oxford University Press

Access to resources Recommend Favorite

Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles

By Peñarrubia J  

Human Reproduction, Vol. 13, Iss. 12, 1998-12 ,pp. : 3315-3318

Oxford University Press

Access to resources Recommend Favorite

Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone

By Weissman A  

Human Reproduction, Vol. 13, Iss. 12, 1998-12 ,pp. : 3421-3424

Oxford University Press

Access to resources Recommend Favorite

Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF

By Janssens RMJ   Vermeiden JPW   Lambalk CB   Schats R   Schoemaker J  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2386-2391

Oxford University Press

Access to resources Recommend Favorite